Mirae Asset Global ETFs Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
+12,170
New +$2.09M ﹤0.01% 1170
2025
Q3
– Sell
-32,500
Closed -$4.11M – 3121
2025
Q2
$4.11M Buy
+32,500
New +$3.99M 0.01% 798
2024
Q3
– Sell
-33,532
Closed -$4.6M – 3126
2024
Q2
$4.6M Buy
+33,532
New +$4.48M 0.01% 770

Other funds holding IBB

Mirae Asset Global ETFs Holdings's IBB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 12,170 shares worth $2.31M. The stake represents ﹤0.01% of the portfolio and ranks #1170 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in IBB as recently as Q2 2025.

Mirae Asset Global ETFs Holdings first reported a position in IBB in Q2 2024 and has held it in 3 quarters since. The position peaked at $4.6M in Q2 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 12,170 shares of iShares Biotechnology ETF worth $2.31M as of Q2 2026.
  • iShares Biotechnology ETF was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1170 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 3 quarters since.
  • Mirae Asset Global ETFs Holdings's iShares Biotechnology ETF position peaked at $4.6M in Q2 2024.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.